How do personalized cancer vaccines work?

Personalized cancer vaccines work by targeting specific mutations present in a patient's cancer cells. These vaccines are designed to stimulate the patient's immune system to recognize and attack the cancer cells more effectively.

Types of personalized cancer vaccines

There are two main types of personalized cancer vaccines: mRNA vaccines and neoantigen vaccines. mRNA vaccines deliver genetic material to cells to produce specific proteins that trigger an immune response. Neoantigen vaccines are tailored to target mutations found in the patient's tumor cells.

Effectiveness in treating various types of cancer

Personalized cancer vaccines have shown promising results in treating various types of cancer, including melanoma, lung cancer, and bladder cancer. They have the potential to improve outcomes for patients by specifically targeting cancer cells while minimizing damage to healthy cells.

Creating personalized vaccines

To create a personalized cancer vaccine, a patient's tumor is sequenced to identify specific mutations. These mutations are then used to design a vaccine that can target the unique features of the patient's cancer cells.

Overall, personalized cancer vaccines represent a promising approach in cancer immunotherapy and targeted therapy, offering a tailored treatment option for patients based on their individual cancer mutations.